The relationship between plasma leptin levels and chronic complication in patients with type 2 diabetes mellitus

Metabolic Syndrome and Related Disorders

Volumn 8, Issue 6, 2010, Pages 499-503

  Sari, Ramazan ^a   Balci, Mustafa Kemal ^a   Apaydin, Cemil ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; ARTICLE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SMOKING; VASCULAR DISEASE;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CHRONIC DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY;

EID: 78649963610     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2009.0127     Document Type: Article

References (38)

1. Lee TS, Saltsman KA., Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 1989;86: 5141-5145.
2. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996;124:136-145.
3. Bain SC, Chowdhury TA. Genetics of diabetic nephropathy and microalbuminuria. J R Soc Med 2000;93:62-66.
4. Knowler WC, Bennett PH, Ballintine EJ. Increased incidence of diabetic retinopathy with elevated blood pressure. N Engl J Med 1980;302:645-650.
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
6. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-215.
7. Barash IA, Cheung CC, Weigle DS, Ren H, Kabigting EB, Kuijper JL, Clifton DK, Steiner RA. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996;137: 3144-3147.
8. Ozata M, Ozisik G, Bingol N, Corakci A, Gundogan MA. The effects of thyroid status on plasma leptin levels in women. J Endocrinol Invest 1998;21:337-341.
9. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996;6:1170-1180.
10. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901.
11. Bouloumie A, Drexler HC, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998;83: 1059-1066.
12. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR. Biological action of leptin as an angiogenic factor. Science 1998;281:1683-1686.
13. Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Diabet Med 1991;8:263-267.
14. Feldt-Rasmussen B, Mathiesen ER, Hegedus L, Deckert T. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient ne-phropathy. N Engl J Med 1986;314:665-670.
15. Haffner SM, Gingerich RL, Miettinen H, Stern MP. Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes Relat Metab Disord 1996;20:904-908.
16. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: Plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 1997;82:654-657.
17. Gariano RF, Nath AK, D'Amico DJ, Lee T, Sierra-Honigmann MR. Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci 2000;41:3576-3581.
18. Dagogo-JackS, LiuJ,AskariH, Tykodi G, Umamaheswaran I. Impaired leptin response to glucocorticoid as a chronic complication of diabetes. J Diabetes Complications 2000;14:327-332.
19. Nagasaka S, Ishikawa S, Nakamura T, Kawakami A, Rok-kaku K, Hayashi H, Kusaka I, Higashiyama M, Saito T. Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects. Metabolism 1998;47:1391-1396.
20. Fruehwald-Schultes B, Kern W, Beyer J, Forst T, Pfutzner A, Peters A. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbu-minuria. Metabolism 1999;48:1290-1293.
21. Fruehwald-Schultes B, Peters A, Kern W, Beyer J, Pfutzner A. Serum leptin is associated with serum uric acid concen trations in humans. Metabolism 1999;48:677-680.
22. Haluzik M, Sulkova S, Svobodova J, Bedarova V, Bodlakova B, Markova M, Turkova G, Jiskra J, Haas T. Serum leptin levels in diabetic patients on hemodialysis: The relationship to parameters of diabetes metabolic control. Endocr Res 2000;26:303-317.
23. Donahue RP, Zimmet P, Bean JA, Decourten M, DeCarlo Donahue RA, Collier G, Goldberg RB, Prineas RJ, Skyler J, Schneiderman N. Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study. Ann Epidemiol 1999;9:108-113.
24. Targher G, Zenari L, Faccini G, Falezza G, Muggeo M, Zoppini G. Serum leptin concentrations in young smokers with type 1 diabetes. Diabetes Care 2001;24:793.
25. Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y, Shimamoto K. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10: 1171-1174.
26. Hirose H., Saito I., Tsujioka M., Mori M., Kawabe H., Saruta T. The obese gene product, leptin: possible role in obesity-related hypertension in adolescents. J Hypertens 1998;16: 2007-2012.
27. Suter PM, Locher R, Hasler E, Vetter W. Is there a role for the ob gene product leptin in essential hypertension? Am J Hypertens 1998;11:1305-1311.
28. Onions KL, Hunt SC, Ratowski MP, Klanke CA, Su YR, Reif M, Menon AB. Genetic markers at the leptin (ob) locus are not significantly linked to hypertension in African Americans. Hypertension 1998;31:1230-1238.
29. Zietz B, Schaffler A, Buttner R, Scholmerich J, Palitzsch KD. Elevated levels of leptin and insulin but not of TNF alpha are associated with hypertension in type 2 diabetic males. Exp Clin Endocrinol Diabetes 2000;1084:259-264.
30. Asakawa H, Tokunaga K, Kawakami F. Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients. J Diabetes Complications 2001;15:57-62.
31. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996;45:988-991.
32. Ronnemaa T, Laakso M, Pyorala K, Kallio V, Puukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 1991;11:80-90.
33. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, Olsson T. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999;246:409-418.
34. Soderberg S Ahren B, Stegmayr B, Johnson O, Wiklund PG, Weinehall L, Hallmans G, Olsson T. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 1999;30:328-337.
35. Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001;157:495-503.
36. Uckaya G, Ozata M, Bayraktar Z, Erten V, Bingol N, Ozdemir IC. Is leptin associated with diabetic retinopathy? Diabetes Care 2000;23:371-376.
37. Wilson C, Nelson R, Nicolson M, Pratley R. Plasma leptin concentrations: no difference between diabetic Pima Indians with and without nephropathy. Diabetologia 1998;41:861-862.
38. Gottsater A, Ahren B, Sundkvist G. The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy. Diabetes Care 1999;22:1913-1914.